Stephen M. Robbins

Affiliations: 
University of Calgary, Calgary, Alberta, Canada 
Area:
Cell Biology, Molecular Biology
Google:
"Stephen Robbins"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Corredor JC, Redding N, Bloté K, et al. (2016) N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells Molecular Therapy - Oncolytics. 3
Ahn BY, Saldanha-Gama RF, Rahn JJ, et al. (2015) Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)/CD271) requires regulated interaction with PDLIM1. Oncogene
Sarkar S, Zemp FJ, Senger D, et al. (2015) ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells. Neuro-Oncology. 17: 1095-105
Nguyen SA, Stechishin OD, Luchman HA, et al. (2014) Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4894-903
Sarkar S, Döring A, Zemp FJ, et al. (2014) Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells. Nature Neuroscience. 17: 46-55
Sarkar S, Döring A, Zemp FJ, et al. (2013) Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells. Annals of Neurosciences. 20: 154
Li SS, Kyei SK, Timm-McCann M, et al. (2013) The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients. Cell Host & Microbe. 14: 387-97
Robbins SM, Senger DL. (2013) Assessing mechanisms of glioblastoma invasion Neuromethods. 77: 275-298
Hoegg MB, Robbins SM, McGhee JD. (2012) Characterization of the C. elegans erlin homologue. Bmc Cell Biology. 13: 2
Long EM, Klimowicz AC, Paula-Neto HA, et al. (2011) A subclass of acylated anti-inflammatory mediators usurp Toll-like receptor 2 to inhibit neutrophil recruitment through peroxisome proliferator-activated receptor gamma. Proceedings of the National Academy of Sciences of the United States of America. 108: 16357-62
See more...